In lung cancer cells, it exerts anti-angiogenesis activity by suppressing CoCl2- and EGF-induced VEGF protein production, mRNA expression, HIF-1α expression, and HRE promoter activity [78]. This evidence concerns the gene VEGFA and lung cancer.